NGM BIOPHARMACEUTICALS INC Uncategorized Contracts & Agreements
13 Contracts & Agreements
- Offer Letter and Arbitration Agreement, by and between the Registrant and Jean-Frdric Viret, Ph.D., dated as of October 20, 2023 (Filed With SEC on March 11, 2024)
- Offer Letter Agreement, by and between the Registrant and Valerie L. Pierce, dated as of August 6, 2019, and related information (Filed With SEC on March 11, 2024)
- Offer Letter Agreement, by and between the Registrant and Hsiao D. Lieu, M.D., dated as of January 16, 2019 (Filed With SEC on March 11, 2024)
- Offer Letter and Arbitration Agreement, by and between the Registrant and Jean-Frdric Viret, Ph.D., dated as of October 20, 2023 (Filed With SEC on November 2, 2023)
- Amendment No. 1 to Open Market Sale AgreementSM, dated June 7, 2023, between the Company and Jefferies (Filed With SEC on June 8, 2023)
- Offer Letter Agreement, by and between the Registrant and Hsiao D. Lieu, M.D., dated as of January 16, 2019 (Filed With SEC on February 28, 2023)
- Amendment No. 9 on November (Filed With SEC on March 1, 2022)
- Offer Letter Agreement, by and between the Registrant and Valerie L. Pierce, dated as of August 6, 2019, and related information (Filed With SEC on May 6, 2021)
- Offer Letter Agreement, by and between the Registrant and Hsiao D. Lieu, M.D., dated as of January 16, 2019 (Filed With SEC on May 6, 2021)
- Letter Agreement, dated as of March 12, 2021, by and between Merck Sharp & Dohme Corp. and NGM Biopharmaceuticals, Inc (Filed With SEC on March 15, 2021)
- Offer Letter Agreement, by and between the Registrant and Siobhan Nolan Mangini, dated as of May 20, 2020 (Filed With SEC on August 12, 2020)
- Letter Agreement, by and between NGM Biopharmaceuticals, Inc. and Merck Sharp & Dohme Corp., dated as of March 15, 2019 (Filed With SEC on March 25, 2019)
- Letter Agreement, by and between NGM Biopharmaceuticals, Inc. and Merck Sharp & Dohme Corp., dated as of March 20, 2015 (Filed With SEC on September 28, 2018)
